Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, Lavori P, Howland R, Kling MA, Rittberg B, Carpenter L, Ninan P, Moreno F, Schwartz T, Conway C, Burke M, Barry JJ. Rush AJ, et al. Among authors: howland r. Biol Psychiatry. 2005 Sep 1;58(5):355-63. doi: 10.1016/j.biopsych.2005.05.024. Biol Psychiatry. 2005. PMID: 16139581 Clinical Trial.
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, Rapaport MH, Zajecka J, Nierenberg AA, Husain MM, Ginsberg D, Cooke RG. Rush AJ, et al. Among authors: howland r. Biol Psychiatry. 2005 Sep 1;58(5):347-54. doi: 10.1016/j.biopsych.2005.05.025. Biol Psychiatry. 2005. PMID: 16139580 Clinical Trial.
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, Goodnick P. George MS, et al. Among authors: howland r. Biol Psychiatry. 2005 Sep 1;58(5):364-73. doi: 10.1016/j.biopsych.2005.07.028. Biol Psychiatry. 2005. PMID: 16139582 Clinical Trial.
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, Kornstein SG, Dunner DL, Markowitz JC, Hirschfeld RM, Keitner GI, Zajecka J, Kocsis JH, Russell JM, Miller I, Manber R, Arnow B, Rothbaum B, Munsaka M, Banks P, Borian FE, Keller MB. Gelenberg AJ, et al. Among authors: howland r. Biol Psychiatry. 2003 Oct 15;54(8):806-17. doi: 10.1016/s0006-3223(02)01971-6. Biol Psychiatry. 2003. PMID: 14550680 Clinical Trial.
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB. Schatzberg AF, et al. Among authors: howland r. Arch Gen Psychiatry. 2005 May;62(5):513-20. doi: 10.1001/archpsyc.62.5.513. Arch Gen Psychiatry. 2005. PMID: 15867104 Clinical Trial.
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M; STAR*D Study Team. Trivedi MH, et al. Among authors: howland rh. Am J Psychiatry. 2006 Jan;163(1):28-40. doi: 10.1176/appi.ajp.163.1.28. Am J Psychiatry. 2006. PMID: 16390886 Clinical Trial.
334 results